Hostname: page-component-586b7cd67f-t7fkt Total loading time: 0 Render date: 2024-12-01T03:57:56.279Z Has data issue: false hasContentIssue false

Apoptosis And Resistance To Anti-Microtubule Agents

Published online by Cambridge University Press:  02 July 2020

M. C. Willingham*
Affiliation:
Department of Pathology, Wake Forest University School of Medicine, Winston-Salem, NC27157
Get access

Extract

Several clinically important anti-cancer agents exert their effects on tumor cells through interference with the function of microtubules. In addition to the Vinca alkaloids, such as vinblastine and vincristine, the taxanes, such as paclitaxel (Trade Name: Taxol), kill tumor cells through a microtubular target. Treatment with taxol leads to the inability of microtubules to depolymerize, leading to the formation of large intracellular microtubular bundles. In tumor cells that progress through the cell cycle, this leads to the inability of these cells to disassembly interphase microtubule networks and a failure to form functional mitotic spindles. These cells arrest in M phase, from which they eventually progress, either by the induction of apoptotic cell death, or by micronucleation and the formation of tetraploid cells. There is also the possibility that taxol has other effects on the regulation of genes or other systems to enhance cell killing, perhaps through lowering the threshold of cells to the induction of apoptotic cell death.

Type
Chemotherapeutic Agents That Affect Microtubules: Mechanisms of Response and Chemotherapeutic Agents and Microtubules
Copyright
Copyright © Microscopy Society of America

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Gottesman, M.M. et al., Curr. Opin. Genet. Develop. 6(1996)610.CrossRefGoogle Scholar
2.Collins, J.A. et al., J. Histochem. Cytochem. 45(1997)923.CrossRefGoogle Scholar